Citation 178932

BREGMAN,MD: MEYSKENS JR,FL:. (1983). INHIBITION OF HUMAN MALIGNANT MELANOMA COLONY-FORMING CELLS IN VITRO BY PROSTAGLANDIN A-1.. 43(4)

Citation Details

Title	INHIBITION OF HUMAN MALIGNANT MELANOMA COLONY-FORMING CELLS IN VITRO BY PROSTAGLANDIN A-1.
Authors	BREGMAN,MD: MEYSKENS JR,FL:
Year	1983
Volume	43
Issue	4

Summary

Year: 1983

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN A-1	ACTIVE
2	CYCLIC AMP STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN A-1	INACTIVE
3	CYCLIC AMP INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN A-1	INACTIVE
4	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN A-1	ACTIVE
5	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN A-1	ACTIVE
6	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN A-1	ACTIVE
7	CYCLIC AMP STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN A-1	WEAK ACTIVITY
8	CYCLIC GMP STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN A-1	INACTIVE
9	CYCLIC GMP INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN A-1	INACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN A-2	WEAK ACTIVITY
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN A-2	ACTIVE
12	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN E-1	ACTIVE
13	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN E-1	ACTIVE
14	CYCLIC AMP STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN E-1	WEAK ACTIVITY
15	CYCLIC GMP STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN E-1	WEAK ACTIVITY
16	CYCLIC AMP STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN E-1	INACTIVE
17	CYCLIC AMP INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN E-1	INACTIVE
18	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN B-1	ACTIVE
19	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN B-1	INACTIVE
20	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN B-1	INACTIVE
21	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN F-1-ALPHA	INACTIVE
22	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN F-1-ALPHA	INACTIVE
23	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN F-1-ALPHA	INACTIVE
24	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN F-2-ALPHA	INACTIVE
25	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN F-2-ALPHA	INACTIVE
26	COLONY FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROSTAGLANDIN F-2-ALPHA	INACTIVE
27	CYCLIC AMP STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN F-2-ALPHA	ACTIVE
28	CYCLIC GMP STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN F-2-ALPHA	INACTIVE
29	CYCLIC GMP INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTAGLANDIN F-2-ALPHA	INACTIVE

Citation 178932

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1